Concepedia

Publication | Open Access

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

DOIFull Paper Access

45

Citations

23

References

2022

Year

Ryan W. Dellinger, Holly E. Holmes, T. Hu-Seliger, Rodney Butt, Stephen A. Harrison, Dariush Mozaffarian, Oliver Chen, Leonard Guarente
Hepatology

Abstract

This study demonstrates that NRPT at the recommended dose is safe and may hold promise in lowering markers of hepatic inflammation in patients with NAFLD.

References

YearCitations

Page 1